Tag: precision oncology
Boehringer bets up to $1B on RNA splicing targets from Envisagenics
The New York company will mine alternative splicing for tumor-specific targets that drug makers can turn into therapies.
Lung cancer AI outpredicts PD-L1 on who benefits from immunotherapy
A Nature Medicine study spanning six countries found AI models beat standard biomarkers at forecasting immunotherapy response in advanced lung…
Proteomics model picks breast cancer drugs from biopsies
A virtual-cell model trained on 38 million protein measurements matched real treatment outcomes in women with triple-negative breast cancer.
Cureety absorbs Reimagine Care to watch cancer patients between visits
Cureety acquires Reimagine Care, pairing AI-driven triage with oncology clinical teams across 250 centers.
Caris data tie machine-picked therapies to longer cancer survival
Caris data tie its AI-guided therapy recommendations to longer survival in pancreatic cancer patients.
Cancer trial matchmaker Massive Bio climbs OpenAI partner ranks
The oncology trial matching company joins OpenAI's Select tier to pair frontier models with cancer care workflows.
Tempus PRISM2 pathology model answers diagnostics from plain prompts
Tempus's PRISM2 foundation model matches or beats rivals on diagnostic and prognostic pathology tasks.
AI model predicts immunotherapy response across cancer types
COMPASS, a pan-cancer foundation model, outperforms 22 methods across 16 clinical cohorts by analyzing tumor transcriptomes through immune concepts.